Actimed Therapeutics Secures Additional £4.75M Funding In Series A Extension Round, Almost Doubling Series A Proceeds
Amount Raised
£4.75 Million
Round Type
Series A
AscotBiotechnologyHealth CareMedicalTherapeuticsDescription
London, UK – 22 August 2023 Actimed Therapeutics Ltd (“Actimed”), a UK based clinical stage specialty pharmaceutical company focused on bringing innovation to the treatment of cancer cachexia and other muscle wasting disorders, today announces it has raised a further £4.75m in an extension to its recent Series A financing round which was completed in June this year.
Quick answer
Actimed Therapeutics raised £4.75 Million in a Series A round, dated August 22, 2023. Actimed Therapeutics is based in Ascot, Berkshire, United Kingdom.
- How much did Actimed Therapeutics raise?
- Actimed Therapeutics raised £4.75 Million in a Series A round on August 22, 2023.
- What does Actimed Therapeutics do?
- Actimed Therapeutics is a clinical stage speciality pharmaceutical company focused on bringing innovation to the treatment of muscle wasting disorders to transform the care of an underserved and vulnerable patient..
- Where is Actimed Therapeutics based and how big is it?
- Actimed Therapeutics is based in Ascot, Berkshire, United Kingdom. Fundz records about 10 employees.
- Who are the decision-makers at Actimed Therapeutics?
- Fundz holds 1 contact at Actimed Therapeutics, including the CEO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Therapeutics around the same time
Companies in the same sectors as Actimed Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Qihan Biotech raised an undisclosed amount (Series B) on September 23, 2023.
- Renibus Therapeutics raised an undisclosed amount (Series B) on September 12, 2023.
- Aptose Biosciences raised $3M (Seed) on September 6, 2023.
- Ikena Oncology raised $43M on August 4, 2023.
- Renibus Therapeutics raised $47M (Funding Round) on July 18, 2023.
- Inovedis raised an undisclosed amount (Series A) on October 5, 2023.
Who to call at Actimed Therapeutics, and when
A new round usually means Actimed Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Actimed Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Actimed Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Actimed Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Actimed Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansActimed Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.